Cargando…
Phosphocreatine Interacts with Phospholipids, Affects Membrane Properties and Exerts Membrane-Protective Effects
A broad spectrum of beneficial effects has been ascribed to creatine (Cr), phosphocreatine (PCr) and their cyclic analogues cyclo-(cCr) and phospho-cyclocreatine (PcCr). Cr is widely used as nutritional supplement in sports and increasingly also as adjuvant treatment for pathologies such as myopathi...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422282/ https://www.ncbi.nlm.nih.gov/pubmed/22912820 http://dx.doi.org/10.1371/journal.pone.0043178 |
_version_ | 1782241027840540672 |
---|---|
author | Tokarska-Schlattner, Malgorzata Epand, Raquel F. Meiler, Flurina Zandomeneghi, Giorgia Neumann, Dietbert Widmer, Hans R. Meier, Beat H. Epand, Richard M. Saks, Valdur Wallimann, Theo Schlattner, Uwe |
author_facet | Tokarska-Schlattner, Malgorzata Epand, Raquel F. Meiler, Flurina Zandomeneghi, Giorgia Neumann, Dietbert Widmer, Hans R. Meier, Beat H. Epand, Richard M. Saks, Valdur Wallimann, Theo Schlattner, Uwe |
author_sort | Tokarska-Schlattner, Malgorzata |
collection | PubMed |
description | A broad spectrum of beneficial effects has been ascribed to creatine (Cr), phosphocreatine (PCr) and their cyclic analogues cyclo-(cCr) and phospho-cyclocreatine (PcCr). Cr is widely used as nutritional supplement in sports and increasingly also as adjuvant treatment for pathologies such as myopathies and a plethora of neurodegenerative diseases. Additionally, Cr and its cyclic analogues have been proposed for anti-cancer treatment. The mechanisms involved in these pleiotropic effects are still controversial and far from being understood. The reversible conversion of Cr and ATP into PCr and ADP by creatine kinase, generating highly diffusible PCr energy reserves, is certainly an important element. However, some protective effects of Cr and analogues cannot be satisfactorily explained solely by effects on the cellular energy state. Here we used mainly liposome model systems to provide evidence for interaction of PCr and PcCr with different zwitterionic phospholipids by applying four independent, complementary biochemical and biophysical assays: (i) chemical binding assay, (ii) surface plasmon resonance spectroscopy (SPR), (iii) solid-state (31)P-NMR, and (iv) differential scanning calorimetry (DSC). SPR revealed low affinity PCr/phospholipid interaction that additionally induced changes in liposome shape as indicated by NMR and SPR. Additionally, DSC revealed evidence for membrane packing effects by PCr, as seen by altered lipid phase transition. Finally, PCr efficiently protected against membrane permeabilization in two different model systems: liposome-permeabilization by the membrane-active peptide melittin, and erythrocyte hemolysis by the oxidative drug doxorubicin, hypoosmotic stress or the mild detergent saponin. These findings suggest a new molecular basis for non-energy related functions of PCr and its cyclic analogue. PCr/phospholipid interaction and alteration of membrane structure may not only protect cellular membranes against various insults, but could have more general implications for many physiological membrane-related functions that are relevant for health and disease. |
format | Online Article Text |
id | pubmed-3422282 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-34222822012-08-21 Phosphocreatine Interacts with Phospholipids, Affects Membrane Properties and Exerts Membrane-Protective Effects Tokarska-Schlattner, Malgorzata Epand, Raquel F. Meiler, Flurina Zandomeneghi, Giorgia Neumann, Dietbert Widmer, Hans R. Meier, Beat H. Epand, Richard M. Saks, Valdur Wallimann, Theo Schlattner, Uwe PLoS One Research Article A broad spectrum of beneficial effects has been ascribed to creatine (Cr), phosphocreatine (PCr) and their cyclic analogues cyclo-(cCr) and phospho-cyclocreatine (PcCr). Cr is widely used as nutritional supplement in sports and increasingly also as adjuvant treatment for pathologies such as myopathies and a plethora of neurodegenerative diseases. Additionally, Cr and its cyclic analogues have been proposed for anti-cancer treatment. The mechanisms involved in these pleiotropic effects are still controversial and far from being understood. The reversible conversion of Cr and ATP into PCr and ADP by creatine kinase, generating highly diffusible PCr energy reserves, is certainly an important element. However, some protective effects of Cr and analogues cannot be satisfactorily explained solely by effects on the cellular energy state. Here we used mainly liposome model systems to provide evidence for interaction of PCr and PcCr with different zwitterionic phospholipids by applying four independent, complementary biochemical and biophysical assays: (i) chemical binding assay, (ii) surface plasmon resonance spectroscopy (SPR), (iii) solid-state (31)P-NMR, and (iv) differential scanning calorimetry (DSC). SPR revealed low affinity PCr/phospholipid interaction that additionally induced changes in liposome shape as indicated by NMR and SPR. Additionally, DSC revealed evidence for membrane packing effects by PCr, as seen by altered lipid phase transition. Finally, PCr efficiently protected against membrane permeabilization in two different model systems: liposome-permeabilization by the membrane-active peptide melittin, and erythrocyte hemolysis by the oxidative drug doxorubicin, hypoosmotic stress or the mild detergent saponin. These findings suggest a new molecular basis for non-energy related functions of PCr and its cyclic analogue. PCr/phospholipid interaction and alteration of membrane structure may not only protect cellular membranes against various insults, but could have more general implications for many physiological membrane-related functions that are relevant for health and disease. Public Library of Science 2012-08-17 /pmc/articles/PMC3422282/ /pubmed/22912820 http://dx.doi.org/10.1371/journal.pone.0043178 Text en © 2012 Tokarska-Schlattner et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Tokarska-Schlattner, Malgorzata Epand, Raquel F. Meiler, Flurina Zandomeneghi, Giorgia Neumann, Dietbert Widmer, Hans R. Meier, Beat H. Epand, Richard M. Saks, Valdur Wallimann, Theo Schlattner, Uwe Phosphocreatine Interacts with Phospholipids, Affects Membrane Properties and Exerts Membrane-Protective Effects |
title | Phosphocreatine Interacts with Phospholipids, Affects Membrane Properties and Exerts Membrane-Protective Effects |
title_full | Phosphocreatine Interacts with Phospholipids, Affects Membrane Properties and Exerts Membrane-Protective Effects |
title_fullStr | Phosphocreatine Interacts with Phospholipids, Affects Membrane Properties and Exerts Membrane-Protective Effects |
title_full_unstemmed | Phosphocreatine Interacts with Phospholipids, Affects Membrane Properties and Exerts Membrane-Protective Effects |
title_short | Phosphocreatine Interacts with Phospholipids, Affects Membrane Properties and Exerts Membrane-Protective Effects |
title_sort | phosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effects |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422282/ https://www.ncbi.nlm.nih.gov/pubmed/22912820 http://dx.doi.org/10.1371/journal.pone.0043178 |
work_keys_str_mv | AT tokarskaschlattnermalgorzata phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects AT epandraquelf phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects AT meilerflurina phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects AT zandomeneghigiorgia phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects AT neumanndietbert phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects AT widmerhansr phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects AT meierbeath phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects AT epandrichardm phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects AT saksvaldur phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects AT wallimanntheo phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects AT schlattneruwe phosphocreatineinteractswithphospholipidsaffectsmembranepropertiesandexertsmembraneprotectiveeffects |